# C3J Therapeutics

C3J Therapeutics is an other based in Stevens Point, Indianapolis, Boston, Melbourne, Radford, Germantown, Roanoke, Oak Brook, Marina del Rey, San Diego, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Stevens Point, Indianapolis, Boston, Melbourne, Radford, Germantown, Roanoke, Oak Brook, Marina del Rey, San Diego, United States
- **Region:** North America
- **Assets under management:** Undisclosed
- **Website:** https://c3jtherapeutics.com

## Regulatory record

- **Reports private funds:** No

## About

C3J Therapeutics is a privately held biotechnology company. The name implies a focus on complement cascade therapeutics, specifically targeting the C3 protein, a central node in the innate immune system. Dysregulation of the complement pathway is implicated in numerous diseases including age-related macular degeneration, paroxysmal nocturnal hemoglobinuria, and various autoimmune conditions. No public disclosures detail specific pipeline candidates, funding history, or leadership. Based on available public records, C3J Therapeutics may have ties to academic or biotech hubs in the United States such as Boston or San Diego, though this is unconfirmed. The broader landscape includes well-capitalized competitors such as Apellis Pharmaceuticals and Alexion Pharmaceuticals, which have advanced complement inhibitors to market. No recent operational events are publicly documented for C3J Therapeutics within the last 24 months. The absence of a public web presence and lack of named principals make it difficult to assess the firm's scale, team composition, or strategic direction. It is possible the entity is a shell or dormant organization, or it may be operating under a different name. The most distinguishing feature of C3J Therapeutics is its apparent exclusivity of focus on the complement C3 target, a narrow therapeutic space that requires significant scientific expertise. However, the lack of verifiable operations or public information strongly limits any institutional assessment. This profile should be treated as highly preliminary until further details emerge.

## Questions

### Who founded or leads C3J Therapeutics?

Public sources do not list founders, executive team members, or board members for C3J Therapeutics. The firm has no known presence on professional networking platforms or in industry publications. Without this information, it is not possible to attribute leadership or scientific expertise.

### What is the known funding history of C3J Therapeutics?

No funding rounds, venture capital investments, or grants associated with C3J Therapeutics are documented in public databases or news reports. Without investment activity, the firm's financial backing and valuation remain unknown.

## Related profiles

- [Corvesta](https://altss.com/profile/corvesta)
- [Pinyin Capital Management](https://altss.com/profile/pinyin-capital-management)

---

Updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/c3j-therapeutics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology